日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dissecting the Balance Between Metabolic and Oncogenic Functions of Astrocyte-Elevated Gene-1/Metadherin

剖析星形胶质细胞升高的基因 1/元黏附素的代谢和致癌功能之间的平衡

Yetirajam Rajesh, Saranya Chidambaranathan Reghupaty, Rachel G Mendoza, Debashri Manna, Indranil Banerjee, Mark A Subler, Korri Weldon, Zhao Lai, Shah Giashuddin, Paul B Fisher, Arun J Sanyal, Rebecca K Martin, Mikhail G Dozmorov, Jolene J Windle, Devanand Sarkar

Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network

炎性乳腺癌通过复杂的趋化因子网络促进 M2 肿瘤相关巨噬细胞和癌症间充质细胞的发展

Amanda Valeta-Magara, Abhilash Gadi, Viviana Volta, Beth Walters, Rezina Arju, Shah Giashuddin, Hua Zhong, Robert J Schneider

IGFBP7 Deletion Promotes Hepatocellular Carcinoma

IGFBP7 缺失促进肝细胞癌

Maaged Akiel, Chunqing Guo, Xia Li, Devaraja Rajasekaran, Rachel G Mendoza, Chadia L Robertson, Nidhi Jariwala, Fang Yuan, Mark A Subler, Jolene Windle, Dawn K Garcia, Zhao Lai, Hung-I Harry Chen, Yidong Chen, Shah Giashuddin, Paul B Fisher, Xiang-Yang Wang, Devanand Sarkar

Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming

mTOR 和 eIF4E 的 MNK1 磷酸化过度活跃,通过选择性 mRNA 翻译重编程产生他莫昔芬耐药性和雌激素不依赖性

Phillip A Geter, Amanda W Ernlund, Sofia Bakogianni, Amandine Alard, Rezina Arju, Shah Giashuddin, Abhilash Gadi, Jacqueline Bromberg, Robert J Schneider

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy

过度活化的 mTOR 和 JAK2/STAT3 通路:新辅助化疗后炎症性和浸润性导管乳腺癌的分子驱动因素和潜在治疗靶点

Komal Jhaveri, Eleonora Teplinsky, Deborah Silvera, Amanda Valeta-Magara, Rezina Arju, Shah Giashuddin, Yasmeen Sarfraz, Melissa Alexander, Farbod Darvishian, Paul H Levine, Salman Hashmi, Ladan Zolfaghari, Heather J Hoffman, Baljit Singh, Judith D Goldberg, Tsivia Hochman, Silvia Formenti, Francisc